Target Trial Emulation brings the logic of randomized trials into real-world data
Target Trial Emulation does not replace randomized controlled trials, but it applies their logic and rigor to real-world data analysis.
The newest Biobanking in Finland & Personalized Medicine magazine has now been published.
In the magazine, our experts explain why Finland is the ideal country to conduct biobank and real-world evidence (RWE) research. The article also summarizes briefly the results of our recent biobank report.
The magazine itself gives a comprehensive picture of biobanks and biobank research.
Read the digital version of the whole magazine here. You can find our article from the pages 22-23.
Target Trial Emulation does not replace randomized controlled trials, but it applies their logic and rigor to real-world data analysis.
The data team keeps Medaffcon's research projects on track and ensures that the research findings are scientifically sound. At the heart of the team’s work is the processing and analysis of patient data, particularly in Real-World Evidence (RWE) studies.
Medaffcon's European Lung Cancer Congress (ELCC) poster showcased key findings from a recent study on non-small cell lung cancer (NSCLC).